Differences d’immunogenicite des vaccins anti-SRAS-CoV-2 mRNA-1273 (Moderna) et BNT162b2 (Pfizer-BioNTech) chez les patients dialyses

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC9259426 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature